Sotomayor EM - Search Results

1

Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40.

Sotomayor EM, Borrello I, Tubb E, Rattis FM, Bien H, Lu Z, Fein S, Schoenberger S, Levitsky HI. Sotomayor EM, et al. Nat Med. 1999 Jul;5(7):780-7. doi: 10.1038/10503. Nat Med. 1999. PMID: 10395323

2

Tolerance and cancer: a critical issue in tumor immunology.

Sotomayor EM, Borrello I, Levitsky HI. Sotomayor EM, et al. Crit Rev Oncog. 1996;7(5-6):433-56. doi: 10.1615/critrevoncog.v7.i5-6.30. Crit Rev Oncog. 1996. PMID: 9467666 Review.

3

A universal granulocyte-macrophage colony-stimulating factor-producing bystander cell line for use in the formulation of autologous tumor cell-based vaccines.

Borrello I, Sotomayor EM, Cooke S, Levitsky HI. Borrello I, et al. Among authors: sotomayor em. Hum Gene Ther. 1999 Aug 10;10(12):1983-91. doi: 10.1089/10430349950017347. Hum Gene Ther. 1999. PMID: 10466632

4

In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance.

Sotomayor EM, Borrello I, Tubb E, Allison JP, Levitsky HI. Sotomayor EM, et al. Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11476-81. doi: 10.1073/pnas.96.20.11476. Proc Natl Acad Sci U S A. 1999. PMID: 10500201 Free PMC article.

5

Sustaining the graft-versus-tumor effect through posttransplant immunization with granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing tumor vaccines.

Borrello I, Sotomayor EM, Rattis FM, Cooke SK, Gu L, Levitsky HI. Borrello I, et al. Among authors: sotomayor em. Blood. 2000 May 15;95(10):3011-9. Blood. 2000. PMID: 10807763 Free article.

6

Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression.

Sotomayor EM, Borrello I, Rattis FM, Cuenca AG, Abrams J, Staveley-O'Carroll K, Levitsky HI. Sotomayor EM, et al. Blood. 2001 Aug 15;98(4):1070-7. doi: 10.1182/blood.v98.4.1070. Blood. 2001. PMID: 11493453 Free article.

7

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression.

Staveley-O'Carroll K, Sotomayor E, Montgomery J, Borrello I, Hwang L, Fein S, Pardoll D, Levitsky H. Staveley-O'Carroll K, et al. Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1178-83. doi: 10.1073/pnas.95.3.1178. Proc Natl Acad Sci U S A. 1998. PMID: 9448305 Free PMC article.

8

CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes.

Lu Z, Yuan L, Zhou X, Sotomayor E, Levitsky HI, Pardoll DM. Lu Z, et al. J Exp Med. 2000 Feb 7;191(3):541-50. doi: 10.1084/jem.191.3.541. J Exp Med. 2000. PMID: 10662799 Free PMC article.

9

Cancer vaccines for hematologic malignancies.

Borrello IM, Sotomayor EM. Borrello IM, et al. Among authors: sotomayor em. Cancer Control. 2002 Mar-Apr;9(2):138-51. doi: 10.1177/107327480200900206. Cancer Control. 2002. PMID: 11965234 Free article. Review.

10

Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: dominant role of cross-tolerance to tumor antigens.

Cuenca A, Cheng F, Wang H, Brayer J, Horna P, Gu L, Bien H, Borrello IM, Levitsky HI, Sotomayor EM. Cuenca A, et al. Among authors: sotomayor em. Cancer Res. 2003 Dec 15;63(24):9007-15. Cancer Res. 2003. PMID: 14695219

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters